Sasipong, N. (2020). Targeted overexpression of relaxin receptor 1 (RXFP1) with chronic administration of relaxin as a novel inotropic approach for heart failure treatment. https://doi.org/10.11588/heidok.00027301
Chicago-Zitierstil (17. Ausg.)Sasipong, Nuttarak. Targeted Overexpression of Relaxin Receptor 1 (RXFP1) with Chronic Administration of Relaxin as a Novel Inotropic Approach for Heart Failure Treatment. Heidelberg, 2020. https://doi.org/10.11588/heidok.00027301.
MLA-Zitierstil (9. Ausg.)Sasipong, Nuttarak. Targeted Overexpression of Relaxin Receptor 1 (RXFP1) with Chronic Administration of Relaxin as a Novel Inotropic Approach for Heart Failure Treatment. 2020. https://doi.org/10.11588/heidok.00027301.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.